Toward Greater Transparency at the FDA—Now Is the Time to Act

Key Points

• The aim is to assess and improve the FDA's transparency in its regulatory processes.
• Analyzed the FDA's current transparency practices and policies.
• Identified gaps and challenges in the existing framework.
• Established recommendations for enhanced transparency measures.
• Highlighted the need for improved communication with the public.
• Emphasized the importance of transparency in building public trust.
• Called for immediate action to implement transparency initiatives.